Laser capture microdissection: techniques and applications in liver diseases

被引:29
作者
Aguilar-Bravo, Beatriz [1 ]
Sancho-Bru, Pau [1 ,2 ]
机构
[1] Inst Invest Biomed August Pi & Sunyer IDIBAPS, C Rossello 149-153,Third Floor, Barcelona 08036, Spain
[2] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain
关键词
Laser capture microdissection; Liver diseases; Tissue preservation; Transcriptome; Proteome; Downstream analysis; HEPATIC PROGENITOR-CELL; EXPRESSION; MARKER; PROGRESSION; HEPATOCYTES; MUTATIONS; TARGET; INJURY; STROMA; DNA;
D O I
10.1007/s12072-018-9917-3
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Routine transcriptomic and proteomic analysis are usually performed at a whole organ or tissue level. These approaches provide an average readout of all cell types present within the tissue but do not allow differentiating the profile of specific cell populations. Laser capture microdissection (LCM) constitutes an excellent tool to isolate cell populations or areas of interest within a tissue. By direct visualization, the selected area is excised by a laser and can be further processed for a variety of downstream analyses. This technology has been widely used in the study of liver diseases, from DNA and RNA sequencing to mass spectrometry. However, LCM also has important limitations. To ensure the best integrity of the molecule of interest, optimal tissue preservation, careful tissue sectioning, and optimization of the staining procedure are required. The present review provides a description of the LCM technology, including tips and technical recommendations to perform the procedure, as well as an overview of studies using LCM technology in the field of liver disease.
引用
收藏
页码:138 / 147
页数:10
相关论文
共 51 条
[1]   Hepatocarcinogenesis in non-cirrhotic liver is associated with a reduced number of clonal hepatocellular patches in non-tumorous liver parenchyma [J].
Adam, Alexander C. ;
Faudou, Viola ;
Paschen, Stefan A. ;
Adam, Olaf M. ;
Kahl, Philip ;
Drebber, Uta ;
Fischer, Hans-Peter ;
Buettner, Reinhard .
JOURNAL OF PATHOLOGY, 2012, 228 (03) :333-340
[2]   Genomic and Genetic Characterization of Cholangiocarcinoma Identifies Therapeutic Targets for Tyrosine Kinase Inhibitors [J].
Andersen, Jesper B. ;
Spee, Bart ;
Blechacz, Boris R. ;
Avital, Itzhak ;
Komuta, Mina ;
Barbour, Andrew ;
Conner, Elizabeth A. ;
Gillen, Matthew C. ;
Roskams, Tania ;
Roberts, Lewis R. ;
Factor, Valentina M. ;
Thorgeirsson, Snorri S. .
GASTROENTEROLOGY, 2012, 142 (04) :1021-U552
[3]   Micro-RNA-130a-3p Regulates Gemcitabine Resistance via PPARG in Cholangiocarcinoma [J].
Asukai, Kei ;
Kawamoto, Koichi ;
Eguchi, Hidetoshi ;
Konno, Masamitsu ;
Asai, Ayumu ;
Iwagami, Yoshifumi ;
Yamada, Daisaku ;
Asaoka, Tadafumi ;
Noda, Takehiro ;
Wada, Hiroshi ;
Gotoh, Kunihito ;
Nishida, Naohiro ;
Satoh, Taroh ;
Doki, Yuichiro ;
Mori, Masaki ;
Ishii, Hideshi .
ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (08) :2344-2352
[4]   Gene expression profiling in biliary epithelial cells of primary biliary cirrhosis using laser capture microdissection and cDNA microarray [J].
Baba, Nobuyuki ;
Kobashi, Haruhiko ;
Yamamoto, Kazuhide ;
Terada, Ryo ;
Suzuki, Takahiro ;
Hakoda, Tomomi ;
Okano, Nobuaki ;
Shimada, Noriaki ;
Fujioka, Shin-Ichi ;
Iwasaki, Yoshiaki ;
Shiratori, Yasushi .
TRANSLATIONAL RESEARCH, 2006, 148 (03) :103-113
[5]   RNA-sequencing-based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers [J].
Ceulemans, An ;
Verhulst, Stefaan ;
Van Haele, Matthias ;
Govaere, Olivier ;
Ventura, Juan-Jose ;
van Grunsven, Leo A. ;
Roskams, Tania .
CELL DEATH & DISEASE, 2017, 8 :e3164-e3164
[6]   The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma [J].
Chen, Lei ;
Yan, He-Xin ;
Yang, Wen ;
Hu, Liang ;
Yu, Le-Xin ;
Liu, Qiong ;
Li, Liang ;
Huang, Dan-Dan ;
Ding, Jin ;
Shen, Feng ;
Zhou, Wei-Ping ;
Wu, Meng-Chao ;
Wang, Hong-Yang .
JOURNAL OF HEPATOLOGY, 2009, 50 (02) :358-369
[7]  
Chiu K-W, 2018, BIOMED RES INT, V2018, P1
[8]  
Datta S, 2015, HISTOL HISTOPATHOL, V30, P1255, DOI 10.14670/HH-11-622
[9]   Expression of deleted in malignant brain tumours 1 (DMBT1) relates to the proliferation and malignant transformation of hepatic progenitor cells in hepatitis B virus-related liver diseases [J].
Deng, Huan ;
Gao, Ya-Bo ;
Wang, Hua-Feng ;
Jin, Xiao-Long ;
Xiao, Jia-Cheng .
HISTOPATHOLOGY, 2012, 60 (02) :249-260
[10]   Mass Spectrometry Imaging, Laser Capture Microdissection, and LC-MS/MS of the Same Tissue Section [J].
Dilillo, Marialaura ;
Pellegrini, Davide ;
Ait-Belkacem, Rima ;
de Graaf, Erik L. ;
Caleo, Matteo ;
McDonnell, Liam A. .
JOURNAL OF PROTEOME RESEARCH, 2017, 16 (08) :2993-3001